BMI Trajectories from Birth to 23 Years by Cardiometabolic Risks in Young Adulthood
Author
dc.contributor.author
East, Patricia
Author
dc.contributor.author
Delker, Erin
Author
dc.contributor.author
Blanco, Estela
Author
dc.contributor.author
Lozoff, Betsy
Author
dc.contributor.author
Correa, Paulina
Author
dc.contributor.author
Burrows, Raquel
Author
dc.contributor.author
Gahagan, Sheila
Admission date
dc.date.accessioned
2020-05-04T15:58:37Z
Available date
dc.date.available
2020-05-04T15:58:37Z
Publication date
dc.date.issued
2020
Cita de ítem
dc.identifier.citation
Obesity | volume 28 | number 4 | april 2020
es_ES
Identifier
dc.identifier.other
10.1002/oby.22754
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/174274
Abstract
dc.description.abstract
Objective The aim of this study was to investigate whether the level, rate, and acceleration of BMI growth differ according to the presence or absence of adult cardiometabolic (CM) risks.
Methods BMI was measured in 1,000 Chileans at nine time points from birth to 23 years, and metabolic syndrome and its components were assessed at young adulthood. BMI growth was analyzed in the following three developmental periods: birth to 6 months, 6 months to 5 years, and 5 to 23 years.
Results Individuals with CM risks had a specific constellation of early-life growth (faster growth after infancy, lower BMI decline approaching age 5, absence of a definitive BMI nadir in early childhood, higher 5-year BMI) and distinct young adult growth (larger BMI increases from childhood to young adulthood and lower levels of expected growth deceleration approaching young adulthood). Those with CM risks also attained BMI >= 25 at significantly younger ages than those absent risks (metabolic syndrome: 12.3 years vs. 20.1 years; hyperglycemia: 13.1 years vs. 18.9 years; hypertension: 13.2 years vs. 19.4 years; hypertriglyceridemia: 14.3 years vs. 19.5 years; inflammation: 15.9 years vs. 20.6 years).
Conclusions Larger and faster increases in BMI and a failure of BMI growth to decline or decelerate at specific developmental periods distinguished individuals who would and would not have adult CM risks.
es_ES
Patrocinador
dc.description.sponsorship
United States Department of Health & Human Services
National Institutes of Health (NIH) - USA
R01-HL-088530
R01-HD-033487
T32-HL-079891
R03-HD-097295